Literature DB >> 2001787

Advances in Alzheimer's disease.

R Katzman1, T Saitoh.   

Abstract

The problem of the etiology of Alzheimer's disease has not been solved. But in the past several years there have been significant extensions of our knowledge of the disease and advances in determining the molecular changes underlying the disorder. There is now convincing evidence that the dementia per se is caused by loss of neurons and synapses, particularly in neocortex and hippocampus. The molecular aspects of amyloid and its precursor protein have been defined. The nature of intracellular changes leading to accumulation of the paired helical filament is beginning to be understood. For the first time, putative risk factors can be described in terms of pathogenetic mechanisms. Thus, it may become possible in the not-too-distant future to discover interventions that will slow the progress of this devastating disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001787

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  65 in total

Review 1.  Acetylcholinesterase inhibitors in Alzheimer's disease.

Authors:  B M McGleenon; K B Dynan; A P Passmore
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

2.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 3.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

4.  A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  P G Vallet; R Guntern; P R Hof; J Golaz; A Delacourte; N K Robakis; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Protective effect of isorhynchophylline against β-amyloid-induced neurotoxicity in PC12 cells.

Authors:  Yan-Fang Xian; Zhi-Xiu Lin; Qing-Qiu Mao; Siu-Po Ip; Zi-Ren Su; Xiao-Ping Lai
Journal:  Cell Mol Neurobiol       Date:  2011-11-01       Impact factor: 5.046

Review 6.  Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.

Authors:  Giovanni Scapagnini; Sonya Vasto; Vasto Sonya; Nader G Abraham; Abraham G Nader; Calogero Caruso; Caruso Calogero; Davide Zella; Galvano Fabio
Journal:  Mol Neurobiol       Date:  2011-04-19       Impact factor: 5.590

Review 7.  Alzheimer's disease: fundamental and therapeutic aspects.

Authors:  M Schorderet
Journal:  Experientia       Date:  1995-02-15

Review 8.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

9.  Aging changes in voltage-gated calcium currents in hippocampal CA1 neurons.

Authors:  L W Campbell; S Y Hao; O Thibault; E M Blalock; P W Landfield
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

Review 10.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.